Christina Applegate’s MS Misdiagnosis: When Medicine Stops Asking Questions

Published on

Imagine spending five years taking heavy-duty neurological medications and reshaping your life around an incurable disease. Then, your doctor tells you that you never had it in the first place.

Want to see more Nurse Approved articles in your Google results? Add us as a preferred source.

Add Nurse Approved as a
preferred source on Google

That is what Christina Applegate recently shared on the October 20, 2026 episode of her MeSsy podcast. After going public with her multiple sclerosis (MS) diagnosis in 2021, the actress revealed that her physician confirmed she does not have MS. And here is the part every clinician needs to sit with: her symptoms haven’t gone anywhere. She still faces debilitating physical limitations. Now, her team is running a new round of tests for conditions that mimic MS including lupus, rheumatoid arthritis, and Lyme disease.

As a nurse practitioner, Applegate’s story hits a nerve because we have all seen how fast a label sticks in modern medicine. It forces a question we can never afford to stop asking: Are we treating the patient in front of us, or are we just treating what’s typed in the chart?

Why Clinicians Frequently Misdiagnose Multiple Sclerosis

Clinicians frequently misdiagnose multiple sclerosis because there is no single blood test or definitive biomarker that proves a patient has it. Instead, MS remains largely a diagnosis of exclusion. Providers must piece together a patient’s history, neurological exams, MRI scans, and lab work. At the same time, they have to rule out other autoimmune, infectious, and neurological conditions that look just like it.

That is what makes MS so tricky in real-world practice. Unlike conditions that a simple lab panel can confirm, diagnosing MS takes sharp clinical judgment and constant reassessment. Even worse, classic MS symptoms overlap heavily with dozens of other disorders. Extreme fatigue, muscle weakness, numbness, tingling, vision changes, balance issues, and trouble walking are hallmark signs of MS. Yet none of them belong exclusively to MS. Lupus affecting the nervous system, Lyme disease, rheumatoid arthritis, chronic migraine, spinal cord compression, vitamin B12 deficiency, and peripheral neuropathy all trigger similar symptoms and brain scan changes. The hard part isn’t spotting that something is wrong neurologically. It is proving what is actually driving it.

What the Data Reveals About MS Misdiagnosis

If you think an MS misdiagnosis is a rare fluke, the numbers tell a very different story. Current research shows that roughly 15% of established MS diagnoses—about one in seven patients—are wrong. A 2024 systematic review and meta-analysis led by Wolfgang Emanuel Zürrer and colleagues in Multiple Sclerosis Journal screened 3,910 studies. The team included 62 studies in its qualitative review and 24 in its quantitative analyses. Across the pooled studies, 15% of patients carrying an MS diagnosis did not actually have the disease, with estimates ranging from 9% to 26%. Even more sobering, catching and correcting those mistakes took anywhere from four months to nearly 16 years.

Think about what those lost years look like for a real person. The same review found that up to 60% of misdiagnosed patients took disease-modifying therapies. These aren’t mild daily vitamins. They are powerful immunomodulators and immunosuppressants that slow severe neurological damage, and they carry serious risks like opportunistic infections, liver toxicity, and severe infusion reactions. When clinicians get an MS diagnosis wrong, the patient pays twice. They take on the risks of heavy medications they don’t need, while losing years of real treatment for what is actually making them sick. Diagnostic accuracy isn’t paperwork. It is frontline patient safety.

How Anchoring Bias and Diagnostic Momentum Distort Care

When a wrong diagnosis survives for years across multiple specialists, the problem usually isn’t a lack of medical knowledge. It is human nature baked into busy clinical workflows—specifically, anchoring bias and diagnostic momentum.

Anchoring bias happens when a clinician locks onto the first diagnosis or earliest piece of data they see. Even when new symptoms or test results stop adding up, they fail to pivot. Diagnostic momentum happens next. Providers copy and paste that label across electronic health records, referral notes, and discharge summaries. Soon, the entire care team treats a working theory as a settled fact.

We have all watched this play out on a busy shift. Once “Multiple Sclerosis” lands on a patient’s problem list, it frames every encounter before the patient even opens their mouth. Whether they see a new neurologist, land in the emergency department, or visit primary care, every new ache, tremor, or wave of exhaustion becomes an “MS flare.” Yet having MS doesn’t protect someone from developing another illness. Having MS written in a chart also doesn’t guarantee the original workup got it right. Safe medicine takes clinical humility. It requires stepping back, looking past the chart label, and asking whether the evidence still holds up.

Why Advanced Imaging Still Cannot Replace Clinical Judgment

Diagnostic tools in neurology are getting sharper, and that is good news for patients and clinicians alike. In October 2025, The Lancet Neurology published the 2024 revisions to the McDonald criteria for diagnosing MS, led by Xavier Montalban and colleagues. These updates added new imaging and spinal fluid biomarkers to help separate true MS from look-alike conditions. Tools like the central vein sign and paramagnetic rim lesions on MRI give specialists better clarity when evaluating suspicious white-matter spots. Cerebrospinal fluid kappa free light chains also add valuable diagnostic precision in the right clinical setting.

Still, no MRI scanner or lab assay can practice medicine for us. A scan is just one piece of the puzzle. Clinicians must weigh imaging alongside a thorough physical exam, symptom patterns over time, and a smart differential diagnosis. Better technology helps us ask better questions, but it will never replace our responsibility to keep asking them.

Where Nurses Must Interrupt Diagnostic Momentum

This is where nurses make all the difference. Nurses spend the most continuous time at the bedside and in close conversation with patients. Because of that, we often notice first when a patient’s daily reality refuses to match their chart.

Interrupting diagnostic momentum starts with refusing to let an old diagnosis blind us to a new symptom. A patient living with MS can still have a stroke, an infection, a compressed nerve, or a second autoimmune disease. New weakness, sudden pain, confusion, or an abrupt drop in mobility deserves a real assessment, not an automatic shrug. Just as vital is what we put in the chart. Tracking specific shifts in gait, functional decline, symptom patterns, and unusual medication reactions gives specialists the timeline they need to rethink a case.

Sometimes a patient takes their medications as prescribed and still fails to stabilize, or declines in ways that don’t fit the expected pattern. When that happens, nurses must speak up. Flag the disconnect to the treating provider and back up patients who feel brushed off. Help patients understand what actually supports their diagnosis, and encourage them to ask, “What else could explain these symptoms, and what are we actively ruling out?” That single question turns passive patients into active partners in their own safety.

The Bigger Lesson Beyond Multiple Sclerosis

Christina Applegate’s update is a hard reminder that removing a wrong diagnosis doesn’t magically restore a patient’s health. She is still living with serious physical limitations. She is still hunting for real answers, and she is still counting on a healthcare system to take her symptoms seriously.

For every nurse, nurse practitioner, physician, and healthcare leader, the takeaway goes far beyond multiple sclerosis. A diagnosis should guide our curiosity, not shut it down. The medical record should inform our clinical judgment, not replace it. When the clinical picture changes, our willingness to reconsider must change right along with it. The measure of good medicine is never defending an old label. It is getting it right for the patient.

Alice Benjamin
Alice Benjamin
Alice Benjamin, MSN, ACNS-BC, FNP-C is a board certified nurse practitioner & clinical nurse specialist, mom, health and wellness advocate affectionately known as America's favorite nurse. She is also the Chief Executive Officer & Publisher of the Nurse Approved Network.

SIGN UP FOR THE NEWSLETTER

Subscribe to Stay Credible, Current and Clinically Relevant. Get Nurse News & Education You Can Trust

We don’t spam! Read our privacy policy for more info.

Latest articles

1 in 10 School Nurses Surveyed Report Epinephrine Unavailable During Emergencies

Estimated reading time: 3 minutes When a student has a life-threatening allergic reaction at school, immediate access to epinephrine is critical. Yet new research found...

Nearly 2 in 3 ICU Patients Experience Hospital-Acquired Anemia, Study Finds

Estimated reading time: 4 minutes Nearly two-thirds of intensive care unit patients experienced significant declines in hemoglobin levels during hospitalization, and those patients spent substantially...

They Were Experienced Nurses. Becoming NPs Changed Everything

Estimated reading time: 6 minutes Experienced registered nurses bring years of clinical knowledge and patient care experience to advanced practice. But becoming a nurse practitioner...

Weekly Park Visits Linked to Better Mental Health in Children, Study Finds

Estimated reading time: 3 minutes Children who visited parks and playgrounds at least once a week throughout childhood had fewer emotional and behavioral difficulties than...

Air Force Reservist Pursues Nursing Career to Care for Those Who Serve

Estimated reading time: 4 minutes For Staff Sgt. Melissa Damerow, military service has always been about answering a call to help others. Now, the 33-year-old...

More like this

What If Your Patient’s Newest Diagnosis Is Just a Side Effect? Decoding Prescribing Cascades in Care

Consider a scenario that plays out in ambulatory clinics and hospital wards every single...

Are 8-Year-Olds Too Young for GLP-1s? The Question Healthcare Professionals Should Be Asking

Eight years old is third grade for many children. It’s multiplication tables, playground friendships,...

“Filipino Mafia”: Who Gets to Say It, and When Does It Cross a Line?

Imagine a group of White nurses sitting at the nurses’ station talking about their...